Market Access NICE to consult on inflation-busting fee increases NICE ran a webinar on 2nd November, setting out – ahead of a formal consultation due to open on 21s
News Dismay but little surprise as NICE rejects Alzheimer's drugs Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
